Harmony Biosciences Holdings, Inc.

HRMYNasdaq· Pharmaceutical Preparations

Price History

Revenue

$868.5M

▲ 21.5% YoY

Net Income

$158.7M

▲ 9.1% YoY

EPS

$2.71

▲ 8.0% YoY

Cash

$752.5M

▲ 66.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.